# Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine

> **NCT01021293** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1101 (actual)

## Conditions studied

- Poliomyelitis
- Poliomyelitis Vaccines

## Interventions

- **BIOLOGICAL:** Poliorix™
- **BIOLOGICAL:** Oral Poliovirus vaccine

## Key facts

- **NCT ID:** NCT01021293
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11-28
- **Primary completion:** 2010-07-05
- **Final completion:** 2010-07-05
- **Target enrollment:** 1101 (ACTUAL)
- **Last updated:** 2020-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01021293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01021293, "Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01021293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*